Zona (Shingles)

What is Zona (Shingles)?

Zona, commonly known as shingles, is a painful skin rash caused by the reactivation of the varicella‑zoster virus (VZV) – the same virus that causes chickenpox. After a person recovers from chickenpox, VZV remains dormant in sensory nerve ganglia. When the immune system weakens, the virus can reactivate, travel along the nerve fibers to the skin, and produce the characteristic rash and nerve pain.

Shingles can affect anyone who has had chickenpox, but it most frequently occurs in adults over 50. The rash typically follows a single dermatome (an area of skin supplied by one spinal nerve) and does not cross the midline of the body.

Common Causes

Shingles is not caused by a single factor; rather, it results from a combination of viral latency and reduced immune surveillance. The most important precipitants include:

• Age‑related immune decline – the natural decrease in cell‑mediated immunity after age 50.
• Immunosuppressive medications – corticosteroids, chemotherapy, biologics, or transplant drugs.
• HIV infection – especially when CD4 counts fall below 200 cells/µL.
• Cancers that affect the immune system – such as leukemia, lymphoma, or multiple myeloma.
• Chronic diseases – diabetes mellitus, chronic kidney disease, or COPD, which impair immunity.
• Stress – prolonged psychological or physical stress can dampen immune responses.
• Recent severe illness or surgery – hospitalization, major operations, or severe infections.
• Radiation therapy – especially when directed at the spine or thorax.
• Vaccination status – lack of prior varicella vaccination or inadequate shingles vaccine.
• Genetic predisposition – some studies suggest HLA‑type variations may affect reactivation risk.

Associated Symptoms

Shingles typically follows a predictable pattern, but the severity and associated features can vary:

• Prodromal pain or tingling – burning, itching, or numbness begins 1–5 days before the rash.
• Rash – clusters of red vesicles that become fluid‑filled blisters, then crust over.
• Unilateral distribution – most often on the torso, but can appear on the face, neck, or limbs.
• Post‑herpetic neuralgia (PHN) – persistent nerve pain lasting >90 days after rash resolution.
• Fever, headache, or malaise – systemic symptoms are common, especially in older adults.
• Vision problems – if the ophthalmic branch of the trigeminal nerve is involved (herpes zoster ophthalmicus).
• Hearing loss or vertigo – when the virus involves the ear (Ramsay Hunt syndrome).
• Swollen lymph nodes near the affected dermatome.

When to See a Doctor

Early medical evaluation is crucial because antiviral therapy is most effective when started within 72 hours of rash onset. Seek professional care promptly if you notice any of the following:

• Rash that follows a nerve line, especially if it’s painful or itchy.
• Severe, burning pain that seems out of proportion to the rash.
• Rash on the face, especially near the eye or nose.
• Fever > 101 °F (38.3 °C) combined with rash.
• Weakness, numbness, or tingling in the arms or legs.
• Signs of ocular involvement (red eye, blurry vision, light sensitivity).
• History of immune compromise (organ transplant, HIV, chemotherapy).
• Any sign of spreading infection (rapidly enlarging blisters, foul odor, pus).

People over 50, pregnant women, and those with chronic health conditions should contact a clinician even with milder symptoms.

Diagnosis

Diagnosis of shingles is primarily clinical, based on history and visual inspection. Physicians may use additional tools when the presentation is atypical:

• Physical examination – identification of a unilateral vesicular eruption in a dermatomal pattern.
• Polymerase chain reaction (PCR) testing – swab of vesicular fluid to detect VZV DNA, useful in atypical or disseminated cases.
• Tzanck smear – rapid microscopic exam showing multinucleated giant cells (less specific, rarely used).
• Serology – measurement of VZV IgM/IgG antibodies; helpful only in research settings.
• Ophthalmologic exam – slit‑lamp examination for ocular involvement.
• Neurological assessment – when facial nerve palsy or severe neuropathic pain is present.

Treatment Options

Antiviral Medications

Antivirals reduce severity, accelerate healing, and lower the risk of post‑herpetic neuralgia. Preferred agents include:

• Acyclovir 800 mg five times daily for 7–10 days.
• Valacyclovir 1 g three times daily for 7 days (more convenient dosing).
• Famciclovir 500 mg three times daily for 7 days.

Treatment should begin within 72 hours of rash onset, but may still be beneficial later in high‑risk patients.

Pain Management

• Over‑the‑counter analgesics: acetaminophen or ibuprofen.
• Topical agents: lidocaine patches, capsaicin cream, or calamine lotion.
• Prescription neuropathic pain drugs: gabapentin, pregabalin, or tricyclic antidepressants for PHN.
• Short courses of oral steroids are controversial; they may reduce acute pain but do not prevent PHN.

Supportive Care

• Cool, wet compresses to soothe itching.
• Keeping blisters clean and covered to prevent secondary bacterial infection.
• Loose clothing to reduce friction.
• Rest and adequate hydration.

Home Remedies & Lifestyle

• Apply colloidal oatmeal baths for itch relief.
• Use a soothing oatmeal or baking‑soda paste on affected skin.
• Practice stress‑reduction techniques (deep breathing, meditation) which may lessen pain perception.
• Avoid smoking and limit alcohol, as both can impair immune recovery.

Prevention Tips

• Shingles vaccine – Two vaccines are available in the U.S.:
  • Recombinant zoster vaccine (RZV, Shingrix) – 2 doses, 2–6 months apart; >90 % efficacy, recommended for adults ≥ 50 y.
  • Live attenuated vaccine (ZVL, Zostavax) – single dose; less effective, now less commonly used.
• Stay up‑to‑date with childhood varicella vaccination to reduce initial viral load.
• Maintain a healthy immune system: balanced diet, regular exercise, adequate sleep (7–9 h), and management of chronic diseases.
• Minimize exposure to people with active chickenpox or shingles if you are immunocompromised.
• Practice good hand hygiene and avoid sharing personal items (towels, razors) that might contact vesicular fluid.

Emergency Warning Signs

Key Take‑aways

Shingles is a reactivation of the chickenpox virus that produces a painful, unilateral rash and can lead to serious complications, especially in older adults and those with weakened immune systems. Prompt antiviral treatment within the first 72 hours, appropriate pain control, and vaccination are the cornerstones of management and prevention. If you notice any red‑flag symptoms—particularly eye involvement, facial paralysis, or spreading infection—seek emergency care without delay.

References

• Mayo Clinic. Shingles (herpes zoster). https://www.mayoclinic.org/diseases-conditions/shingles/
• CDC. Shingles (Herpes Zoster) – Prevention & Treatment. https://www.cdc.gov/shingles/
• National Institutes of Health. Herpes Zoster (Shingles) Treatment Guidelines. https://www.niaid.nih.gov/
• Cleveland Clinic. Shingles (Herpes Zoster) Overview. https://my.clevelandclinic.org/health/diseases/16570-shingles
• World Health Organization. Varicella‑zoster virus (VZV) vaccines. https://www.who.int/
• Johnson RW, et al. “Efficacy of the Recombinant Zoster Vaccine (Shingrix) in Adults Aged ≥50 Years.” *New England Journal of Medicine*, 2020.